Blog
RSS FeedPosted by Michael Wonder on 03 Jun 2021
The big pharma firm that saw the future
3 June 2021 - Long ago Roche bet on personalised health care. Now its time has come. ...
Posted by Michael Wonder on 11 Jan 2021
FDA takes steps to provide clarity on developing new drug products in the age of individualised medicine
4 January 2021 - Advances in scientific knowledge and drug development technology have provided an opportunity for new approaches to drug ...
Posted by Michael Wonder on 10 May 2020
COVID-19 raises questions about the value of personalised medicine
8 May 2020 - A group of medical dissenters argues that tailoring treatment to the genetic profiles of individuals, a longstanding ...
Posted by Michael Wonder on 09 Sep 2019
Inside drug makers' strategy to boost cancer medicines with 'Lazarus effect'
6 September 2019 - In the halls of MD Anderson Cancer Center, the drug Vitrakvi is known for having a “Lazarus ...
Posted by Michael Wonder on 28 Aug 2019
FDA warns testing companies: don’t tell patients how their DNA influences response to specific drugs
28 August 2019 - Amid a boom in genetic testing that aims to predict a person’s response to medication, the ...
Posted by Michael Wonder on 12 Sep 2018
Are we being misled about precision medicine?
12 September 2018 - Doctors and hospitals love to talk about the cancer patients they’ve saved, and reporters love to write ...
Posted by Michael Wonder on 28 Aug 2018
Comparison of two treatment models: precision medicine and preventive medicine
28 August 2018 - In an effort to improve the risk-benefit profile of therapies in clinical care, precision medicine seeks to ...
Posted by Michael Wonder on 23 Jul 2018
Precision medicine success hinges on diagnostics' clinical utility
23 July 2018 - The companion diagnostic plays a significant role in precision medicine. ...
Posted by Michael Wonder on 18 Jul 2018
$50 million to provide life-saving support to cancer patients
18 July 2018 - The Australian Government will provide $50 million to support some of Australia’s sickest patients, battling the most ...
Posted by Michael Wonder on 17 Jul 2018
Federal Government to announce $50 million custom cancer drug trial
17 July 2018 - Almost 600 Queenslanders will have their cancer’s DNA tested to identify the drugs that will keep ...
Posted by Michael Wonder on 16 May 2018
Evolving landscape of US FDA drug approval in the era of precision oncology: finding the right balance between access and safety
15 May 2018 - Since 1992, the US FDA has implemented several programs for streamlined review and approval of agents that ...
Posted by Michael Wonder on 08 May 2018
Precision medicines have faster approvals based on fewer and smaller trials than other medicines
7 May 2018 - Precision medicines can benefit patients by increasing the probability of a successful treatment response in selected patient ...
Posted by Michael Wonder on 30 Jan 2018
Transforming health care through precision medicine
31 January 2018 - Lately we've both been enjoying ITV's drama Victoria. By all accounts Queen Victoria lived well, dying ...
Posted by Michael Wonder on 15 Dec 2017
Statement from FDA Commissioner on new FDA efforts to support more efficient development of targeted therapies
15 December 2017 - In recent years, the medical community has experienced a shift in the way health care is ...
Posted by Michael Wonder on 29 Jul 2017
Concept paper on development and lifecycle of personalised medicines and companion diagnostic
28 July 2017 - Public consultation to end on 31 October 2017. ...